Advanced Non-Melanoma Skin Cancer: PD-1–Targeted Therapy
2 vistas
• 07/10/23
0
0
Empotrar
administrator
Suscriptores
Experts reflect on potential benefit with PD-1–targeted therapy in the settings of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC).
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios